Reduction in ephedra poisonings after FDA ban

New England Journal of Medicine

Volumn 372, Issue 22, 2015, Pages 2172-2174

  Zell Kanter, Michele ^a   Quigley, Meghan A ^b   Leikin, Jerrold B ^c  

^a Jr Hospital of Cook County   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE;

CEREBROVASCULAR ACCIDENT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MARKETING; EPHEDRA; FOOD AND DRUG ADMINISTRATION; FOOD POISONING; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEIZURE; SUDDEN DEATH; UNITED STATES; WEIGHT REDUCTION; DRUG RECALL; EPIDEMIOLOGY; INTOXICATION;

EPHEDRA; HUMANS; POISONING; SAFETY-BASED DRUG WITHDRAWALS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84929870371     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1502505     Document Type: Letter

References (5)

1. Palamar J. How ephedrine escaped regulation in the United States: a historical review of misuse and associated policy. Health Policy 2011;99:1-9.
2. Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537-45.
3. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
4. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77:12-6.
5. Woolf AD, Watson WA, Smolinske S, Litovitz T. The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002. Clin Toxicol (Phila) 2005;43:347-55.